Organogenesis Holdings Inc. Class A Common Stock (ORGO) is a publicly traded Healthcare sector company. As of August 24, 2026, ORGO trades at $1.73 with a market cap of $231.61M and a P/E ratio of -2.06. ORGO moved -7.78% today. Year to date, ORGO is -67.76%; over the trailing twelve months it is -65.85%. Its 52-week range spans $1.54 to $7.08. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces ORGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ORGO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ORGO recently traded at $1.73. Market cap is $231.61M. P/E ratio is -2.06. Revenue is $457.45M.
| Metric | Value |
|---|---|
| Price | $1.73 |
| Market Cap | $231.61M |
| P/E Ratio | -2.06 |
| EPS | $-0.82 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.08 |
| 52-Week Low | $1.54 |
| Volume | 701.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $457.45M |
| Net Income | $-84.16M |
| Gross Margin | 0.00% |
2 analysts cover ORGO: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.